Ro-0505124   Click here for help

GtoPdb Ligand ID: 8203

Synonyms: RO0505124 [1]
Compound class: Synthetic organic
Comment: Ro-0505124 is a potent and selective ATP-competitive inhibitor of cyclin-dependent kinase 4 (CDK4) [1-2]. Ro-0505124 is >100 fold selective for CDK4 compared to CDKs 1 and -2 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 121.19
Molecular weight 451.17
XLogP 2.4
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN1CCN(CC1)c1ccc(cc1)Nc1nc(c(s1)C(=O)c1ccc2c(c1)OCCO2)N
Isomeric SMILES CN1CCN(CC1)c1ccc(cc1)Nc1nc(c(s1)C(=O)c1ccc2c(c1)OCCO2)N
InChI InChI=1S/C23H25N5O3S/c1-27-8-10-28(11-9-27)17-5-3-16(4-6-17)25-23-26-22(24)21(32-23)20(29)15-2-7-18-19(14-15)31-13-12-30-18/h2-7,14H,8-13,24H2,1H3,(H,25,26)
InChI Key YGEYFDLYGXSZCP-UHFFFAOYSA-N
References
1. Burgess A, Wigan M, Giles N, Depinto W, Gillespie P, Stevens F, Gabrielli B. (2006)
Inhibition of S/G2 phase CDK4 reduces mitotic fidelity.
J Biol Chem, 281 (15): 9987-95. [PMID:16476733]
2. Ding Q, Gillespie P, Kim K, McComas WW, Perrotta A. (2006)
Diaminothiazoles having antiproliferative activity.
Patent number: US7094896. Assignee: Hoffmann-La Roche Inc.. Priority date: 22/12/2001. Publication date: 22/08/2006.